Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Next chapter for weight controlSmall-molecule GLP-1 receptor agonists
Supports healing without forming scar tissue
With a projected launch in 2026, it represents Eli Lillys bid to expand the companys dominance in the GLP-1R category. China-based Jiangsu Hengruis HRS-9531 is the final Phase III contender and the only one not being developed by pharma giants Novo Nordisk or Eli Lilly
Benefits Supports Healthy Antioxidant Function : S-Phenylacetyl Glutathione replenishes the body's master antioxidant, which becomes depleted through daily environmental and lifestyle stressors
Peripherally circulating GLP-1 (143) and some GLP-1RAs, such as liraglutide and semaglutide (145), can readily access the CVOs, including the subfornical organ and the area postrema, which express GLP-1R and have close neuroanatomical connections with hypothalamus involved in forage and satiety control
